Kristian Gurashi

机构：University of Manchester, MRC Weatherall Institute of Molecular Medicine, MRC Human Immunology Unit, Cancer Research UK Manchester Institute, Oxford BioMedica (United Kingdom) · ORCID：0000-0002-5540-3398

发表论文 29 篇 · 总被引 127 次 · h-index 3

代表论文

• Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils (2023 · Cell stem cell · 被引 67)
• comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders (2026 · Cell stem cell · 被引 9)
• comBO: A combined human bone and lympho-myeloid bone marrow organoid for pre-clinical modelling of haematopoietic disorders (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 3)
• Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study (2024 · Leukemia · 被引 3)
• Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia (2024 · Blood Cancer Journal · 被引 3)
• A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia (2023 · British Journal of Haematology · 被引 3)